Skip to main content
. 2022 Jul 7;24(11):1579–1592. doi: 10.1007/s11912-022-01309-w

Table 2.

Challenges in investigating cardiovascular risk in cancer survivors

• Separating the impact of cancer treatment from the impact of the cancer itself

• Disentangling the impact of cancer and cancer treatment from that of shared risk factors (e.g. smoking, diet, physical activity, comorbidities) and normal ageing

• Adjusting for cancer-related factors in analysis that are often not available in databases (e.g. cancer treatment, cancer stage)

• Adjusting for non-cancer-related factors in analysis (e.g. shared risk factors, comorbidities, competing risk of death)

• Adjusting for the changing cardiovascular risk posed by cancer treatments as these treatments evolve over time

• Ensuring appropriate follow-up to capture late cardiovascular effects of treatment

• Capturing data in adult cohorts in a field where much of the data is in paediatric cohorts